Synopsis
Main goal of in vivo Magnetic Resonance Spectroscopy (MRS)
is the determination of individual metabolite concentrations in organs like the
brain. Spectrally two-dimensional spectroscopy can help to encode more spectral
information during the acquisition, and hence disentangle the overcrowded
proton spectra. In order to quantify the 2D spectra most accurately, it is
necessary to fit them to 2D metabolite basis spectra, hence utilising the full
amount of available prior information. Reasons for fitting along with the actual
fitting methods are explained in this educational talk.
Magnetic resonance spectroscopy (MRS) is a commonly used
technique for clinical studies investigating various (mainly neurological)
disorders. Its main limitations are SNR, spectral overlap and sensitivity to
various artefacts. SNR limits achievable resolution and requires long acquisition
times. Spectral overlap means that from the ~20 potentially detectable
metabolites, people often focus on the three predominant singlets (NAA,
creatine and choline). Sensitivity to artefacts means that great care has to be
taken during acquisition to ensure proper water and fat suppression, good
shimming, and lots of other things. Mainly two approaches exist to get more out
of spectroscopy: increase spatial information by going to chemical-shift
imaging (CSI); increase spectral information by going to two-dimensional
spectroscopy (e.g. 2D JPRESS or COSY), editing (e.g. difference editing or
multiple quantum coherence filtering), higher field strengths (e.g. 7T) and/or
better shimming [1]. This educational talk will focus on 2D spectroscopy, more
specifically on how to extract the maximum amount of information from such
data. In this text, the wording 1D and 2D will always denote spectral
dimensions, and NOT spatial dimensions as used in CSI.
Many of the ~20 metabolites in proton brain MRS resonate at
similar chemical-shift (CS) frequencies [1]. Additionally, most metabolites do
not have a single singlet peak, but are split up into multiplets by J-coupling. Hence, a typical 1D spectrum
is overcrowded with many peaks overlapping each other. It is difficult to
separate for instance glutamate and glutamine at 3T. In order to detect
metabolites and separate their signal contributions from each other, it is
normally required to modify the acquisition to either filter out unwanted
resonances or to encode more spectral information by 2D spectroscopy. The
advantage of filtering is that the acquisition can be highly optimised for a
single metabolite, while the advantage of 2D MRS is that the whole range of
metabolites can potentially be detected in
a single scan. The most common 2D techniques applied
to in vivo MRS are 2D J-resolved
spectroscopy (JPRESS) and 2D COSY [2]. JPRESS uses the PRESS sequence
(90°-180°-180° with slice selection in three orthogonal directions), while COSY
uses a (partly) STEAM based acquisition incorporating at least two 90° pulses
(out of the three pulses required for localising a voxel). JPRESS therefore
exhibits higher SNR, while J-coupled peaks are potentially better separated by
COSY. Main advantage of JPRESS is probably its robustness, especially when
sampling the maximum echo [3].
The most accurate quantification methods for determining
individual metabolite concentrations generally imply spectral fitting. The
physical properties (number of spins, CS frequencies, J-couplings) of in vivo
brain metabolites are well characterised and the resulting spectra can be either
simulated or measured directly in pure phantom solutions. These individual
metabolite spectra can be used as basis set in the fitting function for
determining the individual metabolite concentrations. Fitting a measured
spectrum to the full individual metabolite basis sets incorporates the full
amount of prior information in the quantification, hence yielding potentially
the most accurate concentration values. For 1D MRS quantification, the quasi
golden standard is the commercially available LCModel program (LCMODEL Inc.,
Oakville, ON, Canada) [4]. A non-linear fit determines line-broadening, small shifts,
baseline, phases and line-shape distortions, while the concentrations are
determined using these parameters in a linear least squares fit doing a “Linear Combination of Model
Spectra”. Absolute quantification yielding concentrations in mM (=1 mol/m3)
requires references (such as internal water, external reference phantom, RF),
is challenging and prone to errors. Therefore, concentrations are typically
given as ratios to creatine or water.
Different spectral fitting methods exist for 2D MRS, with
the simplest ones being peak fitting inherited from the NMR field. Another way
is to look at a single cross-section through the 2D spectrum, hence generating
a pseudo 1D spectrum (e.g. called TE-averaged MRS), and applying common 1D
fitting methods such as LCModel to it (Fig. 1). Alas, a lot of spectral
information is not considered by doing this, and the only way to extract the
maximum information out of the 2D spectra is by a linear combination of the
full 2D model spectra. There is no commercially available program existing, but
various methods are described in the literature. The most widely used program
is called Prior-knowledge Fitting
(“ProFit”) [5], which is available for download [6]. It was originally
developed to quantify JPRESS brain spectra, but in the meantime it got adapted
to other organs (prostate) [7] as well as other acquisition methods (COSY) [8].
It is not as automated and easy to use as LCModel.
ProFit consist of a non-linear least squares fit to
determine lineshape (linewidth + distortions), (small) shifts and phases. These
are used to update data or basis functions, in order to determine
concentrations in a linear least-squares fit using the 2D metabolite spectra as
basis function for a linear superposition. In order to decrease computational
complexity, the fits are repeated three times with increasing complexity (first
only singlets, final step all metabolites), initialising the next iteration
with prior results (Fig. 2). Baseline distortions were neglected in the
initial, first ProFit version, but were included into a second version (along
with improved line modelling), thus reducing contamination from macromolecules
and hence improving quantification, at the cost of increased computational
complexity [9]. Basis spectra were simulated with published metabolite
CS-shifts and couplings [10] using GAMMA [11], a quantum-simulation library
developed for NMR.
It is possible to detect and quantify more brain metabolites
as compared to standard 1D PRESS.
Acknowledgements
No acknowledgement found.References
1.
In vivo NMR Spectroscopy. de Graaf, RA. Wiley, 2nd
edition, 2007; ISBN 978-0-470-02670-0.
2.
3D localized 2D NMR spectroscopy on an MRI
scanner. Ryner LN, Sorenson JA, Thomas MA. J Magn Reson B. 1995
May;107(2):126-37.
3.
Improved two-dimensional J-resolved
spectroscopy. Schulte RF, Lange T, Beck J, Meier D, Boesiger P. NMR Biomed.
2006 Apr;19(2):264-70.
4.
Estimation of metabolite concentrations from
localized in vivo proton NMR spectra. Provencher SW. Magn Reson Med. 1993
Dec;30(6):672-9.
5.
ProFit: two-dimensional prior-knowledge fitting
of J-resolved spectra. Schulte RF, Boesiger P. NMR Biomed. 2006
Apr;19(2):255-63.
6.
http://www.biomed.ee.ethz.ch/research/bioimaging/mr-spectroscopy/Software/ProFit
7.
Quantitative J-resolved prostate spectroscopy
using two-dimensional prior-knowledge fitting. Lange T, Schulte RF, Boesiger P.
Magn Reson Med. 2008 May;59(5):966-72.
8.
Two-dimensional MR spectroscopy of healthy and
cancerous prostates in vivo. Thomas MA, Lange T, Velan SS, Nagarajan R, Raman
S, Gomez A, Margolis D, Swart S, Raylman RR, Schulte RF, Boesiger P. MAGMA.
2008 Nov;21(6):443-58.
9.
ProFit revisited. Fuchs A, Boesiger P, Schulte
RF, Henning A. Magn Reson Med. 2014 Feb;71(2):458-68.
10.
Proton NMR chemical shifts and coupling
constants for brain metabolites. Govindaraju V, Young K, Maudsley AA. NMR
Biomed. 2000 May;13(3):129-53.
11.
Computer Simulations in Magnetic Resonance. An
Object Oriented Programming Approach. Smith SA, Levante TO, Meier BH, Ernst RR,
J. Magn. Reson. 1994; 106a:75-105.